Comment on 'Prognostic significance of circulating tumor DNA in urothelial carcinoma: a systematic review and meta-analysis'

Jingwen Zhao¹, Qiang Xu^{2

3

4}

Affiliations

¹ Tianjin University of Traditional Chinese Medicine.
² Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine.
³ Institute of Surgery of Traditional Chinese Medicine.
⁴ Institute of Sores and Ulcers, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.

Jingwen Zhao et al. Int J Surg. 2024.

. 2024 Sep 1;110(9):5895-5896.

doi: 10.1097/JS9.0000000000001657.

Jingwen Zhao¹, Qiang Xu^{2

3

4}

¹ Tianjin University of Traditional Chinese Medicine.
² Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine.
³ Institute of Surgery of Traditional Chinese Medicine.
⁴ Institute of Sores and Ulcers, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.

No abstract available

Conflict of interest statement

The authors declare no conflicts of interest.

1. Liu H, Chen J, Huang Y, et al. . Prognostic significance of circulating tumor DNA in urothelial carcinoma: a systematic review and meta-analysis. Int J Surg 2024;110:3923–36. - PMC - PubMed
1. Li M, Li L, Zheng J, et al. . Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application. Mol Cancer 2023;22:37. - PMC - PubMed
1. Tamura D, Abe M, Hiraki H, et al. . Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma. Cancer Sci 2024;115:529–539. - PMC - PubMed
1. Zhang H, Jin T, Peng Y, et al. . Association between plasma circulating tumor DNA and the prognosis of esophageal cancer patients: a meta-analysis. Int J Surg 2024. doi:10.1097/JS9.0000000000001373. - PMC - PubMed
1. Zhang C, Chen Z, Chong X, et al. . Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2‐targeted therapies. Clin Transl Med 2020;10:e254. - PMC - PubMed